These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33306677)

  • 1. Preclinical approaches in vulvovaginal candidiasis treatment with mucoadhesive thermoresponsive systems containing propolis.
    Bonfim AP; Sakita KM; Faria DR; Arita GS; Vendramini FAVR; Capoci IRG; Braga AG; Dos Santos RS; Bruschi ML; Becker TCA; de Oliveira Junior AG; Kioshima ÉS; de Souza Bonfim-Mendonça P; Svidzinski TIE
    PLoS One; 2020; 15(12):e0243197. PubMed ID: 33306677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole and propolis co-encapsulated in chitosan nanoparticles for the treatment of vulvovaginal candidiasis in a murine model.
    da Silva JT; Dantas de Sousa PH; Costa AF; de Menezes LB; Alves SF; Pellegrini F; Amaral AC
    Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37947253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of mucoadhesive thermoresponsive systems containing propolis for the treatment of vulvovaginal candidiasis.
    Pereira RR; Ribeiro Godoy JS; Stivalet Svidzinski TI; Bruschi ML
    J Pharm Sci; 2013 Apr; 102(4):1222-34. PubMed ID: 23334938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p-Coumaric acid loaded into liquid crystalline systems as a novel strategy to the treatment of vulvovaginal candidiasis.
    Ferreira PS; Victorelli FD; Rodero CF; Fortunato GC; Araújo VHS; Fonseca-Santos B; Bauab TM; Van Dijck P; Chorilli M
    Int J Pharm; 2021 Jun; 603():120658. PubMed ID: 33964336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis.
    Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M
    Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mrr2 mutations and upregulation are associated with increased fluconazole resistance in Candida albicans isolates from patients with vulvovaginal candidiasis.
    Feng W; Yang J; Ji Y; Xi Z; Yang L; Zhu X; Ma Y
    Lett Appl Microbiol; 2020 Feb; 70(2):95-101. PubMed ID: 31705810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis.
    Kenechukwu FC; Attama AA; Ibezim EC; Nnamani PO; Umeyor CE; Uronnachi EM; Gugu TH; Momoh MA; Ofokansi KC; Akpa PA
    Eur J Pharm Sci; 2018 Jan; 111():358-375. PubMed ID: 28986195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal activity of propolis extract against yeasts isolated from vaginal exudates.
    Dalben-Dota KF; Faria MG; Bruschi ML; Pelloso SM; Lopes-Consolaro ME; Svidzinski TI
    J Altern Complement Med; 2010 Mar; 16(3):285-90. PubMed ID: 20192913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of ravuconazole in a murine model of vaginitis by Candida albicans.
    Elizondo-Zertuche M; Robledo-Leal E; González JG; Ceceñas LA; González GM
    Rev Iberoam Micol; 2015; 32(1):30-3. PubMed ID: 24071640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of experimental murine vulvovaginal candidiasis with gentian violet.
    Bonfim AP; Sakita KM; Faria DR; Arita GS; Rodrigues-Vendramini FA; Capoci IR; Braga AG; Mosca VA; Junior AG; Kioshima ÉS; Bonfim-Mendonça PS; Svidzinski TI
    Future Microbiol; 2023 Nov; 18():1137-1146. PubMed ID: 37830930
    [No Abstract]   [Full Text] [Related]  

  • 15. Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis.
    Fernandes Costa A; Evangelista Araujo D; Santos Cabral M; Teles Brito I; Borges de Menezes Leite L; Pereira M; Correa Amaral A
    Med Mycol; 2019 Jan; 57(1):52-62. PubMed ID: 29361177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the cell targets important for propolis-induced cell death in Candida albicans.
    de Castro PA; Bom VL; Brown NA; de Almeida RS; Ramalho LN; Savoldi M; Goldman MH; Berretta AA; Goldman GH
    Fungal Genet Biol; 2013 Nov; 60():74-86. PubMed ID: 23856128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
    Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
    Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
    Zhang X; Li T; Chen X; Wang S; Liu Z
    BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of commercial ethanol propolis extract on the in vitro growth of Candida albicans collected from HIV-seropositive and HIV-seronegative Brazilian patients with oral candidiasis.
    Martins RS; Péreira ES; Lima SM; Senna MI; Mesquita RA; Santos VR
    J Oral Sci; 2002 Mar; 44(1):41-8. PubMed ID: 12058869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Mucoadhesive Gels with Propolis (EPP-AF) in Preclinical Treatment of Candidiasis Vulvovaginal Infection.
    Berretta AA; de Castro PA; Cavalheiro AH; Fortes VS; Bom VP; Nascimento AP; Marquele-Oliveira F; Pedrazzi V; Ramalho LN; Goldman GH
    Evid Based Complement Alternat Med; 2013; 2013():641480. PubMed ID: 23997797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.